Institutional Ownership Verrica Pharmaceuticals Inc. (VRCA)
This table provides information about the institutional ownership of Verrica Pharmaceuticals Inc. (VRCA). We have compiled data on the 55 institutions that hold shares in the stock, with a total of 16.5 Million shares, which have been reported (via 13F filing form) to have a value of $131 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Armistice Capital, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
8,881,344
shares
|
$70.6 Million
1.24% of portfolio
|
Q2 2025
Added 3.66%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
2,168,310
shares
|
$17.2 Million
0.0% of portfolio
|
Q2 2025
Reduced 8.17%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
1,129,143
shares
|
$8.98 Million
0.0% of portfolio
|
Q2 2024
Added 1.35%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
907,076
shares
|
$7.21 Million
0.0% of portfolio
|
Q2 2025
Added 129.26%
|
|
|
Sovran Advisors, LLC
San Diego, CA |
Jul 09, 2025 Q2 2025 |
750,391
shares
|
$5.97 Million
0.07% of portfolio
|
Q2 2025
Added 91.35%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
646,156
shares
|
$5.14 Million
0.0% of portfolio
|
Q2 2025
Reduced 36.56%
|
|
|
Mariner, LLC
Overland Park, KS |
Aug 14, 2025 Q2 2025 |
265,295
shares
|
$2.11 Million
0.0% of portfolio
|
Q2 2025
Added 60.6%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
207,402
shares
|
$1.65 Million
0.0% of portfolio
|
Q2 2025
Reduced 52.29%
|
|
|
Y Intercept (Hong Kong) LTD
|
Aug 01, 2025 Q2 2025 |
186,955
shares
|
$1.49 Million
0.04% of portfolio
|
Q2 2025
New holding
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
175,284
shares
|
$1.39 Million
0.0% of portfolio
|
Q2 2025
Added 26.05%
|
|
|
Bml Capital Management, LLC
Zionsville, IN |
Aug 11, 2025 Q2 2025 |
174,651
shares
|
$1.39 Million
0.07% of portfolio
|
Q4 2024
Reduced 2.97%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
91,816
shares
|
$729,937
0.0% of portfolio
|
Q2 2025
Reduced 83.81%
|
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
87,293
shares
|
$693,979
0.0% of portfolio
|
Q2 2025
Reduced 1.56%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
87,200
shares
|
$693,240
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Steel Peak Wealth Management LLC
|
Jul 22, 2025 Q2 2025 |
76,000
shares
|
$604,200
0.02% of portfolio
|
Q4 2024
Reduced 25.49%
|
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
72,730
shares
|
$578,203
0.0% of portfolio
|
Q2 2025
Reduced 90.8%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
68,660
shares
|
$545,847
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
66,585
shares
|
$529,350
0.0% of portfolio
|
Q2 2025
Added 23.03%
|
|
|
Miracle Mile Advisors, LLC
|
Jul 22, 2025 Q2 2025 |
59,769
shares
|
$475,163
0.01% of portfolio
|
Q2 2025
Reduced 28.85%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Aug 14, 2025 Q2 2025 |
52,955
shares
|
$420,992
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
50,272
shares
|
$399,662
0.0% of portfolio
|
Q2 2025
Reduced 14.37%
|
|
|
Jane Street Group, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
38,330
shares
|
$304,723
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Spc Financial, Inc.
|
Jul 25, 2025 Q2 2025 |
30,000
shares
|
$238,500
0.02% of portfolio
|
Q2 2023
New holding
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Aug 14, 2025 Q2 2025 |
26,886
shares
|
$213,743
0.01% of portfolio
|
Q2 2025
Added 76.39%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
26,266
shares
|
$208,814
0.0% of portfolio
|
Q2 2025
Reduced 62.17%
|